Keyphrases
Imatinib
100%
Uterine Sarcoma
100%
COL1A1-PDGFB Fusion
100%
Uterine Response
100%
Dermatofibrosarcoma Protuberans
33%
Immunohistochemistry
16%
Genetic Modification
16%
Targeted Therapy
16%
CD34
16%
Gene Fusion
16%
Uterus
16%
Accurate Diagnosis
16%
Tyrosine Kinase Inhibitor
16%
Rare Tumors
16%
Potential Response
16%
Spindle Cell Sarcoma
16%
Rare Neoplasm
16%
Fusion Characteristics
16%
Molecular Genetic Methods
16%
Medicine and Dentistry
Imatinib
100%
Platelet Derived Growth Factor B
100%
Uterus Sarcoma
100%
Dermatofibrosarcoma Protuberans
33%
Neoplasm
16%
Immunohistochemistry
16%
Targeted Therapy
16%
Gene Mutation
16%
Recurrent Disease
16%
Gene Fusion
16%
Rare Tumor
16%
Tyrosine-Kinase Inhibitor
16%
Spindle Cell Sarcoma
16%